Iodide

Iodide

SCHEMBL16516285

CCCCCCCCCCCCOc1ccc2c(c1)[n+](C(C)C)cn2C(C)C.[I-]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 1/20 0.39
▸ NR5A1 Q13285 1/20 0.38
▸ TSHR P16473 2/20 0.38
▸ NPC1 O15118 3/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ HTR1B P28222 1/20 0.37
▸ TP53 P04637 3/20 0.36
▸ HPGD P15428 1/20 0.36
▸ CASR P41180 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ APAF1 O14727 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ FGFR1 P11362 1/20 0.35
▸ CNR2 P34972 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL30731322 1.00 LTA4H (0.39) LTA4HNR5A1TSHRNPC1RAB9A
SCHEMBL17916653 0.99 LTA4H (0.40) LTA4HNR5A1TSHRNPC1RAB9A
Bicarbonate SCHEMBL17911341 0.91 TP53 (0.39) TSHRTP53
Iodide SCHEMBL18824159 0.89 FGFR1 (0.38) NPC1RAB9ATP53GAAFGFR1
Bicarbonate SCHEMBL29765454 0.82 TP53 (0.41) TSHRTP53
Bicarbonate SCHEMBL29765538 0.82 TP53 (0.41) TSHRTP53
Bicarbonate SCHEMBL26607957 0.82 TP53 (0.41) TSHRTP53
Bicarbonate SCHEMBL26607969 0.82 TP53 (0.41) TSHRTP53
SCHEMBL23366511 0.81 ADRB2 (0.33) —
SCHEMBL18844586 0.80 APAF1 (0.38) LTA4HCASRLMNAMAPTAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12623250-B2 Carbene-functionalized composite materials QUEEN'S UNIVERSITY AT KINGSTON (CA) 2026-05-12 — — US disclosed
US-12409473-B2 Carbene-functionalized composite materials QUEEN'S UNIVERSITY AT KINGSTON (CA) 2025-09-09 — — US disclosed
US-20240351063-A1 Carbene-Functionalized Composite Materials THE UNIVERSITY OF WESTERN ONTARIO (CA) 2024-10-24 — — US disclosed
US-20240173741-A1 Carbene-Functionalized Composite Materials QUEEN'S UNIVERSITY AT KINGSTON (CA) 2024-05-30 — — US disclosed
US-11840766-B2 Etching metal using N-heterocyclic carbenes QUEEN'S UNIVERSITY AT KINGSTON (CA) 2023-12-12 — — US disclosed
US-11801528-B2 Carbene-functionalized composite materials QUEEN'S UNIVERSITY AT KINGSTON (CA) 2023-10-31 — — US disclosed
US-20220258202-A1 Carbene-Functionalized Composite Materials QUEEN'S UNIVERSITY AT KINGSTON (CA) 2022-08-18 — — US disclosed
US-11383266-B2 Carbene-functionalized composite materials QUEEN'S UNIVERSITY AT KINGSTON (CA) 2022-07-12 — — US disclosed
US-11008291-B2 Methods of forming carbene-functionalized composite materials QUEEN'S UNIVERSITY AT KINGSTON (CA) 2021-05-18 — — US disclosed
US-20200283911-A1 ETCHING METAL USING N-HETEROCYCLIC CARBENES GREENCENTRE CANADA (CA) 2020-09-10 — — US disclosed
US-20190169132-A1 Methods of Forming Carbene-Functionalized Composite Materials QUEEN'S UNIVERSITY AT KINGSTON (CA) 2019-06-06 — — US disclosed
WO-2017075704-A1 METHODS OF FORMING CARBENE-FUNCTIONALIZED COMPOSITE MATERIALS QUEEN'S UNIVERSITY AT KINGSTON (CA) 2017-05-11 — — WO disclosed
US-20160199875-A1 Carbene-Functionalized Composite Materials QUEEN'S UNIVERSITY AT KINGSTON (CA) 2016-07-14 — — US disclosed
EP-3036102-A1 CARBENE FUNCTIONALIZED COMPOSITE MATERIALS Queen's University At Kingston (CA) 2016-06-29 — — EP disclosed
WO-2015024120-A1 CARBENE FUNCTIONALIZED COMPOSITE MATERIALS QUEEN'S UNIVERSITY AT KINGSTON (CA) 2015-02-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12623250-B2 Carbene-functionalized composite materials EPCAM, CAD, CTTN LTA4H 4757/4885NR5A1 1360/4885TSHR 1119/4885
US-11008291-B2 Methods of forming carbene-functionalized composite materials VCL, CHN2, CA3 LTA4H 1152/4885NR5A1 1236/4885TSHR 1595/4885
US-20190169132-A1 Methods of Forming Carbene-Functionalized Composite Materials VCL, CHN2, CA3 LTA4H 1152/4885NR5A1 1236/4885TSHR 1595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback